[9394] found that intravenous infusion of GLP-RA exenatide prior to revascularization in patients with ST-segment elevation myocardial infarction (MI) reduced reperfusion injury and final infarct size, compared with placebo treatment and Woo et al
Key Takeaways Retatrutide touts almost twice the weight loss of Ozempic, with clinical trials revealing consistent results across diverse body types
Contemporary OB-GYN: FDA approves-5-year-use-for-etonogestrel-implant-68-mg-contraceptive Safety Labeling Update for Nexplanon Patient Experiences with Nexplanon Summary of MedWatch Voluntary Reports for Nexplanon (240 reports of device complications for 1,577 reports submitted voluntarily, mainly by consumers) Rare Disease: FDA Approves First Treatment for Children With Menkes Disease The FDA approved the first-ever treatment for Menkes disease: Zydus Life Sciences Zycubo (copper histidinate) daily subcutaneous injection for pediatric patients
Another trial, at the National Institute on Drug Abuse, is recruiting participants to see whether GLP-1s could help people with alcohol use disorder drink less
How Does Shotsy Compare
PCOS affects reproductive, metabolic, and cardiovascular health systems simultaneously Insulin resistance is present in most women with PCOS and drives many symptoms Weight loss of even 5-10% can significantly improve symptoms and restore ovulation The condition creates a vicious cycle where hormonal issues make weight loss difficult Long-term health risks include type 2 diabetes, heart disease, and liver problems What Is Retatrutide and How Does It Work
